Clinical practice guidelines for liver cancer

•       National Comprehensive Cancer Network (US), NCCN clinical practice guidelines in hepatobiliary cancers, version 2.2021 (register for free to access these).

•       American Association for the Study of Liver Diseases, AASLD guidelines for the treatment of hepatocellular carcinoma.

•       European Society for Medical Oncology, Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.

•       European Association for the Study of the Liver, EASL clinical practice guidelines: management of hepatocellular carcinoma.

Optimal cancer care pathways for liver cancer

These clinical guides for health professionals set out key principles for optimal care at each step of the patient journey, from prevention through to survivorship or end-of-life care.

Patients and their families and carers can use the consumer versions to better understand an often complex health system, and to know what questions to ask of their health professionals to ensure that they receive the best care at every step.

Help your patients and their families and carers understand the process they are going through by printing and sharing these guides as appropriate.

•       View the optimal cancer care pathways or download consumer PDFs from www.cancer.org.au/OCP.

•       View the interactive consumer web portal at www.cancerpathways.org.au.

•       View the liver cancer clinical cancer pathway.

Find out more

National Cancer Institute (US), Adult primary liver cancer treatment (PDQ®) – health professional version.

When reading materials that are published in other countries, note that some of the information may not apply to Australian patients.